Nasal residence time and rheological properties of a new bentonite-based thixotropic gel emulsion nasal spray - AM-301

ObjectiveThe present work provides characterization of rheological properties of a new bentonite-based thixotropic gel emulsion nasal spray (AM-301), its nasal residence time, distribution, safety and tolerability.SignificanceThe nasal epithelium is a portal of entry for allergens and primary infection by airborne pathogens. Non-pharmacological interventions, which enhance physical and biological barriers, protect against allergens and pathogens without drug-related side effects. AM-301 has shown promising efficacy and safety in the nasal epithelium against viruses (in vitro) and pollen (clinical).MethodsTechnical part (i) spray characterization was performed with a validated droplet size distribution method; evaluation of the rheological properties of the formulation was performed by a validated amplitude sweep method and a validated oscillation, rotation, oscillation; Clinical part (ii) nasal and oropharyngeal endoscopy were used to provide a semi-quantitative evaluation of distribution and residence time of fluorescein-labelled AM-301 in the nose and oropharynx of healthy volunteers; (iii) tolerability and safety.Results(i) The non-Newtonian rheological properties of the formulation allow AM-301 to be sprayed and then to revert to a gel to prevent run-off from the nasal cavity; (ii) the formulation remains on the inferior turbinate, septum and oropharynx of volunteers for up to 210 min and on the middle turbinate for up to 60 min; two nasal sprays provide no substantial benefit over a single application with regards to coverage or retention; (iii) the spray is well toleratedConclusionsSingle dose spray delivery of AM-301 provides extended coverage of the nasal mucosa up to the inferior turbinates.

Automated summary

This study characterizes the rheological properties of a new bentonite-based thixotropic gel emulsion nasal spray (AM-301), and evaluates its nasal residence time, distribution, safety, and tolerability. The results show that AM-301 provides extended coverage of the nasal mucosa and has a good nasal residence time.